In the current trading session, Kazia Therapeutics Limited’s (KZIA) stock is trading at the price of $2.27, a gain of 27.77% over last night’s close. So, the stock is trading at a price that is -81.53% less than its 52-week high of $12.28 and 39.14% better than its 52-week low of $1.63. Based on the past 30-day period, the stock price is -53.59% below the high and +35.25% above the low.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, KZIA’s SMA-200 is $7.0429.
Furthermore, one should take into account the price to sales ratio of a company for the last year, which is 2.22. KZIA’s price to book ratio for the most recent quarter was 1.31, resulting in an 2.22 price to cash per share for the period.
How does Kazia Therapeutics Limited (KZIA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 2 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.00 in simple terms.
Kazia Therapeutics Limited (NASDAQ: KZIA) Ownership Details
I will give a breakdown of the key shareholders in Kazia Therapeutics Limited (KZIA). Recent figures show that the company’s insiders hold 0.00% of shares. A total of 14 institutional investors hold shares in the company, making 2.68% of its stock and 2.68% of its float.
Mar 30, 2022, it was reported that the Company’s largest institutional holder is Morgan Stanley holding total of 0.29 million shares that make 2.11% of the company’s total number of shares and are currently priced at 0.67 million.
The securities firm Envestnet Asset Management holds 26411.0 shares of KZIA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.19%, and the holding percentage of shares is valued at 60745.0.
An overview of Kazia Therapeutics Limited’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Kazia Therapeutics Limited (KZIA) traded 457,802 shares per day, with a moving average of $3.2415 and price change of -1.87. With the moving average of $4.3361 and a price change of -3.60, about 618,239 shares changed hands on average over the past 50 days. Finally, KZIA’s 100-day average volume is 319,970 shares, alongside a moving average of $5.5814 and a price change of -3.85.